Cannabis Science Inc. is researching on cannabis-based medicines and products. The company is also working on research and development in medical marijuana.

Cannabis Science, Inc. (CBIS) announced the initiation of preclinical development characterization of CS-TATI-I following the execution of contractual retention of vendor labs located in the Amsterdam Life Science Cluster.

Cannabis Science Inc a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.

Cannabis Science, Inc. is researching on cannabis-based medicines and products. The company is also working on research and development in medical marijuana.

Cannabis Science Inc (OTCMKTS:CBIS) decreased -2.02% and closed at $0.0485 on a traded volume of 1.50 million shares, in comparison to 3.66 million shares of average trading volume.

SmartOTC brings a special trend analysis of these stocks: Cannabis Science Inc (OTCMKTS:CBIS), Titan Pharmaceuticals, Inc. (OTCBB:TTNP), Indigo-Energy, Inc. (OTCMKTS:IDGG), avada International Ltd.

Cannabis Science Inc declared that Sacred Cow Production is releasing a film American Drug War II. The film will be publically released nationally on June 6, 2013.

The current traded volume of the company stands at 2.3 million shares which is modestly higher as compared to its average shares of 5.59 million.

Las Vegas, NV -- (SBWIRE) -- 04/22/2013 -- Cannabis Science Inc (PINK:CBIS) announced that Dr. Robert Melamede, the President and CEO of the company has played a production role in Kevin Booth's American Drug War II which is presented by Sacred ...

Cannabis Science Inc (PINK:CBIS) ended higher 0.19% and complete the day at 0.0536. The total number of shares changed hands during the day was 1.06 million.